FR2733984B1 - Derives de tryptamine, leur preparation et les medicaments les contenant - Google Patents

Derives de tryptamine, leur preparation et les medicaments les contenant

Info

Publication number
FR2733984B1
FR2733984B1 FR9505510A FR9505510A FR2733984B1 FR 2733984 B1 FR2733984 B1 FR 2733984B1 FR 9505510 A FR9505510 A FR 9505510A FR 9505510 A FR9505510 A FR 9505510A FR 2733984 B1 FR2733984 B1 FR 2733984B1
Authority
FR
France
Prior art keywords
preparation
products containing
medicinal products
tryptamine derivatives
tryptamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9505510A
Other languages
English (en)
Other versions
FR2733984A1 (fr
Inventor
Dominique Damour
Jean Claude Depezay
Merrer Yves Le
Guy Pantel
Lydie Poitout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9505510A priority Critical patent/FR2733984B1/fr
Priority to PCT/FR1996/000682 priority patent/WO1996035686A1/fr
Priority to AU58400/96A priority patent/AU5840096A/en
Publication of FR2733984A1 publication Critical patent/FR2733984A1/fr
Application granted granted Critical
Publication of FR2733984B1 publication Critical patent/FR2733984B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR9505510A 1995-05-10 1995-05-10 Derives de tryptamine, leur preparation et les medicaments les contenant Expired - Fee Related FR2733984B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9505510A FR2733984B1 (fr) 1995-05-10 1995-05-10 Derives de tryptamine, leur preparation et les medicaments les contenant
PCT/FR1996/000682 WO1996035686A1 (fr) 1995-05-10 1996-05-06 Derives de tryptamine, leur preparation et les medicaments les contenant
AU58400/96A AU5840096A (en) 1995-05-10 1996-05-06 Tryptamine derivatives, preparation thereof and medicaments containing them

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9505510A FR2733984B1 (fr) 1995-05-10 1995-05-10 Derives de tryptamine, leur preparation et les medicaments les contenant

Publications (2)

Publication Number Publication Date
FR2733984A1 FR2733984A1 (fr) 1996-11-15
FR2733984B1 true FR2733984B1 (fr) 1997-07-04

Family

ID=9478822

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9505510A Expired - Fee Related FR2733984B1 (fr) 1995-05-10 1995-05-10 Derives de tryptamine, leur preparation et les medicaments les contenant

Country Status (3)

Country Link
AU (1) AU5840096A (fr)
FR (1) FR2733984B1 (fr)
WO (1) WO1996035686A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE309993T1 (de) * 1997-04-21 2005-12-15 Takeda Pharmaceutical 4,1-benzoxazepine, ihre analoga, und ihre verwendung als somatostatin-agonisten
SE0003795D0 (sv) * 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3430284A1 (de) * 1984-08-17 1986-02-27 Troponwerke GmbH & Co KG, 5000 Köln Neue tryptamin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung
US5278316A (en) * 1989-06-29 1994-01-11 Warner-Lambert Company N-substituted cycloalkyl and polycycloalkyl alpha-substituted Trp-Phe- and phenethylamine derivatives

Also Published As

Publication number Publication date
FR2733984A1 (fr) 1996-11-15
WO1996035686A1 (fr) 1996-11-14
AU5840096A (en) 1996-11-29

Similar Documents

Publication Publication Date Title
MA26685A1 (fr) Derives d'azetidine leur preparation et les medicaments les contenant
FR2735777B1 (fr) Derives de 4-phenylaminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
MA26472A1 (fr) Derives de n-hydroxy-b-sulfonylpropionamide, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26424A1 (fr) Derives de 6-phenylpyridyl-2-amine, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2665159B1 (fr) Nouveaux derives de la pyridine et de la quinoleine, leur preparation et les compositions pharmaceutiques qui les contiennent.
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26505A1 (fr) Derives de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26490A1 (fr) Derives de tetrahydroisoquinoleine nouveaux, procedes pour leur preparation et compositions pharmaceutiques les contenant.
FR2722190B1 (fr) Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
FR2582309B1 (fr) Nouveaux derives du morphinane et de la morphine, leur preparation, leur application comme medicaments et les compositions pharmaceutiques les contenant
FR2628425B1 (fr) Derives d'isoindolinone, leurs procedes de preparation et les medicaments les contenant
FR2687401B1 (fr) Derives de la 1,4-dialkylpiperazine, procedes d'obtention et compositions pharmaceutiques les contenant.
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
FR2717811B1 (fr) Dérivés d'imidazo[1,2-a]pyrazine-4-one, leur préparation et les médicaments les contenant.
MA26441A1 (fr) Derives de pyrrolidinyl- et pyrrolinyl- ethylamine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2743366B1 (fr) Derives de 5h,10h-imidazo(1,2-a)indeno(1,2-e)pyrazine-4-one, leur preparation, leurs intermediaires et les medicaments les contenant
MA26437A1 (fr) Derives de trans-piperazine-1-yl-spiro (cyclohexane-1,1'-isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2772761B1 (fr) Nouveaux derives de n-phenylamide et n-pyridylamide, leur procede de preparation et compositions pharmaceutiques les contenant
FR2733984B1 (fr) Derives de tryptamine, leur preparation et les medicaments les contenant
FR2732681B1 (fr) Derives de 10h-imidazo(1,2-a)indeno(1,2-e)pyrazin-4-one, leur preparation et les medicaments les contenant
FR2738821B1 (fr) Indeno[1,2-e]pyrazin-4-ones, leur preparation et les medicaments les contenant
FR2777280B1 (fr) Derives de ginkgolides, leur procede de preparation et compositions pharmaceutiques les contenant
FR2722786B1 (fr) Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
FR2766181B1 (fr) Derives de polyhydroxybutylpyrazines, leur preparation et les medicaments les contenant

Legal Events

Date Code Title Description
ST Notification of lapse